$2.11
3.44%
Nasdaq, Apr 21, 07:18 pm CET
ISIN
US98986M1036
Symbol
ZYXI

Zynex, Inc. Stock price

$2.18
-0.72 24.83% 1M
-5.77 72.58% 6M
-5.83 72.78% YTD
-9.89 81.94% 1Y
-4.88 69.12% 3Y
-8.85 80.24% 5Y
+1.99 1,030.71% 10Y
Nasdaq, Closing price Thu, Apr 17 2025
+0.03 1.40%
ISIN
US98986M1036
Symbol
ZYXI
Sector

Key metrics

Market capitalization $65.90m
Enterprise Value $100.09m
P/E (TTM) P/E ratio 23.44
EV/FCF (TTM) EV/FCF 8.24
EV/Sales (TTM) EV/Sales 0.52
P/S ratio (TTM) P/S ratio 0.34
P/B ratio (TTM) P/B ratio 1.95
Revenue growth (TTM) Revenue growth 4.36%
Revenue (TTM) Revenue $192.35m
EBIT (operating result TTM) EBIT $5.99m
Free Cash Flow (TTM) Free Cash Flow $12.14m
Cash position $39.63m
EPS (TTM) EPS $0.09
P/E forward negative
P/S forward 0.47
EV/Sales forward 0.72
Short interest 24.16%
Show more

Is Zynex, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Zynex, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Zynex, Inc. forecast:

1x Buy
33%
2x Hold
67%

Analyst Opinions

3 Analysts have issued a Zynex, Inc. forecast:

Buy
33%
Hold
67%

Financial data from Zynex, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
192 192
4% 4%
100%
- Direct Costs 39 39
3% 3%
20%
153 153
5% 5%
80%
- Selling and Administrative Expenses 142 142
9% 9%
74%
- Research and Development Expense - -
-
-
11 11
31% 31%
6%
- Depreciation and Amortization 4.78 4.78
0% 0%
2%
EBIT (Operating Income) EBIT 5.99 5.99
44% 44%
3%
Net Profit 2.99 2.99
69% 69%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Zynex, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zynex, Inc. Stock News

Neutral
GlobeNewsWire
about 6 hours ago
SAN FRANCISCO, April 21, 2025 (GLOBE NEWSWIRE) -- Zynex, Inc. (NASDAQ: ZYXI), the Denver-based medical technology firm, is facing a deepening vortex of financial, regulatory and legal challenges, with RBC Capital Markets reportedly further reducing its outlook on the company's stock. The company faces added pressure from a recently filed securities class action lawsuit, alleging the company mad...
Neutral
Accesswire
2 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zynex To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Zynex between March 13, 2023 and March 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212...
Neutral
PRNewsWire
3 days ago
NEW YORK , April 18, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zynex, Inc. (NASDAQ: ZYXI) between March 13, 2023 and March 11, 2025, both dates inclusive (the "Class Period"), of the important May 19, 2025 lead plaintiff deadline. So What: If you purchased Zynex securities during the Class Period you may be entitled to compe...
More Zynex, Inc. News

Company Profile

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. The company also develops a new blood volume monitor for use in hospitals and surgery centers. Zynex was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.

Head office United States
CEO Thomas Sandgaard
Employees 1,000
Founded 1996
Website www.zynex.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today